BLGO Stock Overview
BioLargo, Inc. invents, develops, and commercializes various platform technologies.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
BioLargo, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.31 |
| 52 Week High | US$0.45 |
| 52 Week Low | US$0.15 |
| Beta | 0.27 |
| 1 Month Change | -15.90% |
| 3 Month Change | 54.17% |
| 1 Year Change | 58.92% |
| 3 Year Change | 55.54% |
| 5 Year Change | 85.00% |
| Change since IPO | -55.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| BLGO | US Chemicals | US Market | |
|---|---|---|---|
| 7D | -3.2% | -2.9% | -3.7% |
| 1Y | 58.9% | 5.6% | 20.2% |
Return vs Industry: BLGO exceeded the US Chemicals industry which returned 5.4% over the past year.
Return vs Market: BLGO exceeded the US Market which returned 20.5% over the past year.
Price Volatility
| BLGO volatility | |
|---|---|
| BLGO Average Weekly Movement | 11.8% |
| Chemicals Industry Average Movement | 5.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BLGO's share price has been volatile over the past 3 months.
Volatility Over Time: BLGO's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 32 | Dennis Calvert | www.biolargo.com |
BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services.
BioLargo, Inc. Fundamentals Summary
| BLGO fundamental statistics | |
|---|---|
| Market cap | US$92.52m |
| Earnings (TTM) | -US$3.50m |
| Revenue (TTM) | US$12.23m |
7.6x
P/S Ratio-26.4x
P/E RatioIs BLGO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BLGO income statement (TTM) | |
|---|---|
| Revenue | US$12.23m |
| Cost of Revenue | US$6.08m |
| Gross Profit | US$6.15m |
| Other Expenses | US$9.66m |
| Earnings | -US$3.50m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.012 |
| Gross Margin | 50.32% |
| Net Profit Margin | -28.65% |
| Debt/Equity Ratio | 14.0% |
How did BLGO perform over the long term?
See historical performance and comparison